Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-FZD10, ONC-005 Vector   (CAT#: GTVCR-WQ2147MR)

This product GTVCR-WQ2147MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting FZD10. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Chimeric
RefSeq NM_007197.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 11211
UniProt ID Q9ULW2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-FZD10, ONC-005 Vector (GTVCR-WQ2147MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1105MR IVTScrip™ pSP6-VEE-mRNA-Anti-EGFR, DC-1630423 Vector Vector DC-1630423
GTVCR-WQ1580MR IVTScrip™ pT7-VEE-mRNA-Anti-KLRC1, IPH-2201 Vector Vector IPH-2201
GTVCR-WQ1610MR IVTScrip™ pSP6-VEE-mRNA-Anti-VSIR, JNJ-61610588 Vector Vector JNJ-61610588
GTVCR-WQ1362MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF10B, HGS-ETR2 Vector Vector HGS-ETR2
GTVCR-WQ2601MR IVTScrip™ pSP6-VEE-mRNA-Anti-NGcGM3, UNII-52G405U1E5 Vector Vector UNII-52G405U1E5
GTVCR-WQ1972MR IVTScrip™ pT7-VEE-mRNA-Anti-IL23A, MK-3222 Vector Vector MK-3222
GTVCR-WQ1342MR IVTScrip™ pSP6-VEE-mRNA-Anti-GHR, GX-H9 Vector Vector GX-H9
GTVCR-WQ2507MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, SJ25C1 scFv-28Z CAR Vector Vector SJ25C1 scFv-28Z CAR
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.